Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELSE
11326
DELISTED
Electro-Sensors
ELSE
| $53.5K | ﹤0.01% |
+13,407
| New | +$54.7K |
|
11327
PUT
Rockwell Medical
RMTI
$31.9M
| $53.3K | ﹤0.01% |
3,030
-90
| -3% | -$1.52K |
|
11328
PUT
SurgePays
SURG
$4.38M
| $53.3K | ﹤0.01% |
16,700
-86,100
| -84% | -$325K |
|
11329
PUT
DocGo
DCGO
$39.1M
| $53.1K | ﹤0.01% |
17,200
-18,700
| -52% | -$61.6K |
|
11330
Entera Bio
ENTX
$552M
| $53.1K | ﹤0.01% |
28,856
-22,772
| -44% | -$49.8K |
|
11331
PUT
SELLAS Life Sciences
SLS
$2.77B
| $53.1K | ﹤0.01% |
44,600
+21,500
| +93% | +$29.3K |
|
11332
CALL
Intellicheck
IDN
$57.8M
| $53K | ﹤0.01% |
15,500
+300
| +2% | +$980 |
|
|
TWOU
11333
DELISTED
2U Inc
TWOU
| $52.5K | ﹤0.01% |
10,242
+4,498
| +78% | +$39K |
|
|
LGO
11334
PUT
Largo
LGO
$79.5M
| $52.5K | ﹤0.01% |
28,400
+6,200
| +28% | +$10.8K |
|
|
RVPH
11335
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $52.5K | ﹤0.01% |
2,051
-10,082
| -83% | -$458K |
|
11336
PUT
Cerus
CERS
$552M
| $52.3K | ﹤0.01% |
29,700
+900
| +3% | +$1.61K |
|
11337
Dyadic International
DYAI
$26.4M
| $52.2K | ﹤0.01% |
35,298
+9,754
| +38% | +$17.1K |
|
11338
CALL
Black Diamond Therapeutics
BDTX
$130M
| $52.2K | ﹤0.01% |
11,200
-10,700
| -49% | -$57.4K |
|
|
BGFV
11339
CALL
DELISTED
Big 5 Sporting Goods
BGFV
| $52.1K | ﹤0.01% |
17,600
+4,900
| +39% | +$16.1K |
|
|
HYPD
11340
Hyperion DeFi Inc
HYPD
$52.7M
| $51.9K | ﹤0.01% |
1,092
+731
| +202% | +$42.4K |
|
|
NBP
11341
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $51.9K | ﹤0.01% |
+31,066
| New | +$55.5K |
|
|
SCPH
11342
CALL
DELISTED
scPharmaceuticals
SCPH
| $51.8K | ﹤0.01% |
11,900
-3,200
| -21% | -$14.1K |
|
11343
Shattuck Labs
STTK
$793M
| $51.4K | ﹤0.01% |
13,328
-338,783
| -96% | -$2.75M |
|
11344
Network-1 Technologies
NTIP
$35.9M
| $51.3K | ﹤0.01% |
28,822
-12,264
| -30% | -$22.6K |
|
11345
CALL
Coherus Oncology
CHRS
$224M
| $51.2K | ﹤0.01% |
29,600
-38,800
| -57% | -$78.1K |
|
11346
CALL
NetSol Technologies
NTWK
$48.1M
| $51.1K | ﹤0.01% |
20,100
-61,000
| -75% | -$161K |
|
|
11347
Rockwell Medical
RMTI
$31.9M
| $50.8K | ﹤0.01% |
2,884
+614
| +27% | +$10.4K |
|
|
CMCM
11348
Cheetah Mobile
CMCM
$94M
| $50.6K | ﹤0.01% |
+12,713
| New | +$58.3K |
|
11349
Compass Therapeutics
CMPX
$438M
| $50.5K | ﹤0.01% |
+50,455
| New | +$73.7K |
|
|
TRVG
11350
PUT
trivago
TRVG
$403M
| $50.5K | ﹤0.01% |
25,100
+3,500
| +16% | +$8.39K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.